Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
$351,166.82
% of Total Estimate Gain
15.68%

Telos Capital Management, Inc.'s SPDR Biotech ETF Holding Summary

As of 2025-03-31, Telos Capital Management, Inc. held - shares of SPDR Biotech ETF(XBI), totaling N/A. This investment constitutes 0% of their stock portfolio, and Telos Capital Management, Inc. now holds 0% of the outstanding SPDR Biotech ETF(XBI) stock.

The initial trade took place in 2022Q2. And since then Telos Capital Management, Inc. has made 6 purchases of XBI, at an average price of $76.98, for a total of 29,101.00 shares. In addition, there have been 6 sales at an average price of $89.05 for 29,101.00 shares. Based on historical transaction data and XBI's current price of $86.27, Telos Capital Management, Inc.'s estimated gain on his XBI holdings is $351,166.82, reflecting a 15.68% gain to date.

Telos Capital Management, Inc. XBI ($86.27) Holding Chart

Telos Capital Management, Inc. XBI ($86.27) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1